Nuwellis, Inc. operates as a medical device company. The company is headquartered in Eden Prairie, Minnesota and currently employs 38 full-time employees. The company went IPO on 2012-02-16. The firm is focused on developing, manufacturing, and commercializing medical devices used in ultrafiltration therapy, including the Aquadex FlexFlow and the Aquadex SmartFlow systems (collectively the Aquadex System). The Aquadex SmartFlow system is indicated for temporary or extended use in adult and pediatric patients weighing 20 kilograms or more whose fluid overload is unresponsive to medical management, including diuretics. The Aquadex System is designed to remove excess fluid from patients suffering from fluid overload who have failed diuretic therapy. The Aquadex System consists of a console, which is a piece of equipment containing electromechanical pumps and a liquid crystal display (LCD) screen; a one-time disposable blood circuit set, which is an integrated collection of tubing, filters, sensors, and connectors that contain and deliver the blood from and back to the patient, and a disposable catheter.
Follow-Up Questions
What is the price performance of NUWE stock?
The current price of NUWE is $3.79, it has increased 0.41% in the last trading day.
What are the primary business themes or industries for Nuwellis Inc?
Nuwellis Inc belongs to Health Care industry and the sector is Health Care
What is Nuwellis Inc market cap?
Nuwellis Inc's current market cap is $3.4M
Is Nuwellis Inc a buy, sell, or hold?
According to wall street analysts, 3 analysts have made analyst ratings for Nuwellis Inc, including 2 strong buy, 4 buy, 1 hold, 0 sell, and 2 strong sell
